JMB

Cited by CrossRef (25)

  1. Tzuriel Sapir, Zaelig Averch, Brian Lerman, Abraham Bodzin, Yeshaya Fishman, Radhashree Maitra. COVID-19 and the Immune Response: A Multi-Phasic Approach to the Treatment of COVID-19. IJMS 2022;23:8606
    https://doi.org/10.3390/ijms23158606
  2. Alexandre de Souza Vieira, Greiciane da Silva Rocha, Lilia de Souza Nogueira. Patients Air Medical Transport During the COVID-19 Pandemic: A Retrospective Cohort Study. Journal of Emergency Nursing 2023;49:962
    https://doi.org/10.1016/j.jen.2023.06.006
  3. Mengyu Guo, Muya Xiong, Jinying Peng, Tong Guan, Haixia Su, Yanyi Huang, Cai-Guang Yang, Yang Li, Diana Boraschi, Thanigaimalai Pillaiyar, Guanbo Wang, Chengqi Yi, Yechun Xu, Chunying Chen. Multi-omics for COVID-19: driving development of therapeutics and vaccines. 2023;10
    https://doi.org/10.1093/nsr/nwad161
  4. Nur Zawanah Zabidi, Hern Liang Liew, Isra Ahmad Farouk, Ashwini Puniyamurti, Ashley Jia Wen Yip, Vindya Nilakshi Wijesinghe, Zheng Yao Low, Julian W. Tang, Vincent T. K. Chow, Sunil K. Lal. Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagnostic Strategies. Viruses 2023;15:944
    https://doi.org/10.3390/v15040944
  5. Nathalie Moussa, Huda Mando. Novel and Predictive QSAR Model and Molecular Docking: New Natural Sulfonamides of Potential Concern against SARS-Cov-2. AIA 2023;21
    https://doi.org/10.2174/2211352521666230717115823
  6. Yungang Lan, Wenqi He, Gaili Wang, Zhenzhen Wang, Yuzhu Chen, Feng Gao, Deguang Song. Potential Antiviral Strategy Exploiting Dependence of SARS-CoV-2 Replication on Lysosome-Based Pathway. IJMS 2022;23:6188
    https://doi.org/10.3390/ijms23116188
  7. Josif Risto, Arjan Hamiti, Enilda Rrapaj. Alternative therapies for viral infections caused by SARS-Cov-2. Fisioter. mov. 2024;37
    https://doi.org/10.1590/fm.2024.37201
  8. Yundi Ma, Jingjing Ren, Yang Zheng, Dongping Cai, Shuai Li, Yangni Li. Chinese parents' willingness to vaccinate their children against COVID-19: A systematic review and meta-analysis. Front. Public Health 2022;10
    https://doi.org/10.3389/fpubh.2022.1087295
  9. Cristina Ferrer-Orta, Sergi Vázquez-Monteagudo, Diego S. Ferrero, Brenda Martínez-González, Celia Perales, Esteban Domingo, Nuria Verdaguer. Point mutations at specific sites of the nsp12–nsp8 interface dramatically affect the RNA polymerization activity of SARS-CoV-2. Proc. Natl. Acad. Sci. U.S.A. 2024;121
    https://doi.org/10.1073/pnas.2317977121
  10. A.H. Sydorenko. ANTIVIRAL DRUGS IN THE TREATMENT FOR COVID-19. Act. Probl. of the Modern Med. 2023;23:156
    https://doi.org/10.31718/2077-1096.23.2.2.156
  11. Shaibu Oricha Bello, Mustapha Umar Imam, Muhammad Bashir Bello, Abdulmajeed Yunusa, Adamu Ahmed Adamu, Abdulmalik Shuaibu, Ehimario Uche Igumbor, Zaiyad Garba Habib, Mustapha Ayodele Popoola, Chinwe Lucia Ochu, Aishatu Yahaya Bello, Yusuf Yahaya Deeni, Ifeoma Okoye. Erythromycin, retapamulin, pyridoxine, folic acid, and ivermectin inhibit cytopathic effect, papain-like protease, and MPRO enzymes of SARS-CoV-2. Front. Cell. Infect. Microbiol. 2023;13
    https://doi.org/10.3389/fcimb.2023.1273982
  12. Arun K. Ghosh, Jennifer L. Mishevich, Andrew Mesecar, Hiroaki Mitsuya. Recent Drug Development and Medicinal Chemistry Approaches for the Treatment of SARS‐CoV‐2 Infection and COVID‐19. ChemMedChem 2022;17
    https://doi.org/10.1002/cmdc.202200440
  13. Sheikh Mohammad Noor-E-Alam, Musarrat Mahtab, Faysal Ahmed, Dulal Chandra Das, Mohammad Abdur Rahim, Swapan Kumar Singha, Syed Abul Foez, Sunia Sinha. Scientific Insights for Drug Development Based on Normal Habitat of Tribal Population of Manipur: An Observational Study Regarding the Implication of “Houttuynia cordata”. 2023;13:142
    https://doi.org/10.5005/jp-journals-10018-1405
  14. Monika Kumari, Ruei-Min Lu, Mu-Chun Li, Jhih-Liang Huang, Fu-Fei Hsu, Shih-Han Ko, Feng-Yi Ke, Shih-Chieh Su, Kang-Hao Liang, Joyce Pei-Yi Yuan, Hsiao-Ling Chiang, Cheng-Pu Sun, I.-Jung Lee, Wen-Shan Li, Hsing-Pang Hsieh, Mi-Hua Tao, Han-Chung Wu. A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies. J Biomed Sci 2022;29
    https://doi.org/10.1186/s12929-022-00852-9
  15. Lang Yuan, Chao Sun, Zeyu Zeng, Haojie Wang. Children aged 0–14 years had a far lower mortality risk during the entire COVID-19 pandemic in four major industrial countries: an observational study. Eur J Pediatr 2024;183:2645
    https://doi.org/10.1007/s00431-024-05522-6
  16. Arun K. Ghosh, Monika Yadav. Synthesis of optically active SARS-CoV-2 Mpro inhibitor drug nirmatrelvir (Paxlovid): an approved treatment of COVID-19. Org. Biomol. Chem. 2023;21:5768
    https://doi.org/10.1039/D3OB00653K
  17. Alejandra García-Aguilar, Rebeca Campi-Caballero, Giovani Visoso-Carvajal, José Rubén García-Sánchez, José Correa-Basurto, Jazmín García-Machorro, Judith Espinosa-Raya. In Vitro Analysis of SARS-CoV-2 Spike Protein and Ivermectin Interaction. IJMS 2023;24:16392
    https://doi.org/10.3390/ijms242216392
  18. Tae-Hun Kim, Sojung Bae, Sunggeun Goo, Jinjong Myoung. Distinctive Combinations of RBD Mutations Contribute to Antibody Evasion in the Case of the SARS-CoV-2 Beta Variant. J. Microbiol. Biotechnol. 2023;33:1587
    https://doi.org/10.4014/jmb.2308.08020
  19. Alejandro Tenorio Pacheco. ¿Cómo cambió mi vida el COVID-19? Una nueva normalidad después de la pandemia. 2024;22:172
    https://doi.org/10.35366/115300
  20. Yifei Wu, Scott D. Pegan, David Crich, Lei Lou, Lauren Nicole Mullininx, Edward B. Starling, Carson Booth, Andrew Edward Chishom, Kuan Y. Chang, Zhong-Ru Xie. Identifying Drug Candidates for COVID-19 with Large-Scale Drug Screening. IJMS 2023;24:4397
    https://doi.org/10.3390/ijms24054397
  21. Eduardo Gallardo-Toledo, Megan Neary, Joanne Sharp, Joanne Herriott, Edyta Kijak, Chloe Bramwell, Paul Curley, Usman Arshad, Henry Pertinez, Rajith K. R. Rajoli, Anthony Valentijn, Helen Cox, Lee Tatham, Anja Kipar, James P. Stewart, Andrew Owen. Chemoprophylactic Assessment of Combined Intranasal SARS-CoV-2 Polymerase and Exonuclease Inhibition in Syrian Golden Hamsters. Viruses 2023;15:2161
    https://doi.org/10.3390/v15112161
  22. Ali S. Faqi. A Comprehensive Guide to Toxicology in Nonclinical Drug Development. 2023.
    https://doi.org/10.1016/B978-0-323-85704-8.00029-3
  23. Xinru Wei, Chunyu Pan, Xizhe Zhang, Weixiong Zhang. Total network controllability analysis discovers explainable drugs for Covid-19 treatment. Biol Direct 2023;18
    https://doi.org/10.1186/s13062-023-00410-9
  24. Yasunari Matsuzaka, Ryu Yashiro. Extracellular Vesicle-Based SARS-CoV-2 Vaccine. Vaccines 2023;11:539
    https://doi.org/10.3390/vaccines11030539
  25. Aleksandra Nowakowska, Hanul Choi, Kihoon Park, Jinha Kim, Yuyeon Jang, Jungmin Chu, Young Bong Kim, Hee-Jung Lee. In vitro Antiviral Activity of Remdesivir Against SARS-CoV-2 and its Variants. J Bacteriol Virol. 2022;52:149
    https://doi.org/10.4167/jbv.2022.52.4.149